- $4.97bn
- $6.18bn
- $4.90bn
- 99
- 51
- 77
- 89
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,887 | 3,462 | 4,254 | 4,631 | 4,905 |
Cost of Revenue | |||||
Gross Profit | 671 | 711 | 947 | 940 | 1,029 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,570 | 3,173 | 3,846 | 4,305 | 4,610 |
Operating Profit | 317 | 288 | 409 | 326 | 295 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 317 | 287 | 384 | 277 | 210 |
Provision for Income Taxes | |||||
Net Income After Taxes | 240 | 215 | 291 | 204 | 162 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 241 | 215 | 291 | 204 | 162 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 241 | 215 | 291 | 204 | 162 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.74 | 3.44 | 4.95 | 3.16 | 3.05 |
Dividends per Share |